Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosis

1. de Andrés, C.
2. Teijeiro, R.
3. Alonso, B.
4. Sánchez-Madrid, F.
5. Martínez, M.L.
6. de Villoria, J.G.
7. Fernández-Cruz, E.
8. Sánchez-Ramón, S.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1371/JOURNAL.PONE.0034103 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus